Acetohydroxamic Acid Interactions

Brand names: Lithostat

Urease Inhibitor · Urease Inhibitors

Route: Oral

Contraindications

Acetohydroxamic acid should not be used in: a. patients whose physical state and disease are amenable to definitive surgery and appropriate antimicrobial agents b. patients whose urine is infected by non-urease producing organisms c. patients whose urinary infections can be controlled by culture-specific oral antimicrobial agents d. patients whose renal function is poor (i.e., serum creatinine more than 2.5 mg/dl and/or creatinine clearance less than 20 ml/min) e. female patients who do not evidence a satisfactory method of contraception f. patients who are pregnant Acetohydroxamic acid may cause fetal harm when administered to a pregnant woman. AHA was teratogenic (retarded and/or clubbed rear leg at 750 mg/kg and above and exencephaly and encephalocele at 1,500 mg/kg) when given intraperitoneally to rats. AHA is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be informed of the potential hazard to the fetus.

Pregnancy & Breastfeeding

(See Contraindications.)

5 interactions on record

AHA chelates iron, reducing absorption of both drugs from the intestinal lumen when taken concomitantly. Intramuscular iron is recommended when iron administration is needed.

Source: NLP:acetohydroxamic acid

No clinically significant interactions noted with concomitant use, though caution advised pending wider clinical experience.

Source: NLP:acetohydroxamic acid

No clinically significant interactions noted with concomitant use, though caution advised pending wider clinical experience.

Source: NLP:acetohydroxamic acid